The Healthcare Distribution Management Association (HDMA) presented its first Distribution Management Award to AmerisourceBergen Packaging Group (ABPG) and Pfizer Pharmaceuticals for its Toviaz™ Physician Sample Package Optimization project. The award, presented at the association’s 2010 Distribution Management Conference & Technology Expo in Baltimore, recognizes member companies’ efforts to improve the efficiency and effectiveness of the healthcare supply chain and enhance trading partner relationships.
Pfizer’s Toviaz, a treatment for overactive bladders, was introduced to the market in 2008 using a child-resistant starter pack for physician samples. In partnership with ABPG company Anderson Packaging, the companies worked together to improve upon this design by transitioning to a more comprehensive package design, using ABPG’s IntuiDose™ child-resistant compliance-prompting format. This enhanced design helped Pfizer to deliver the medication more effectively and cost-efficiently. The improvements resulted in savings in the Toviaz physician sample program and a more patient-friendly product. The new packaging helped to lower processing and operation costs and led to more efficient transportation and distribution.
The Distribution Management Award is the successor to HDMA’s iBusiness Solution and Innovation for Success Awards. HDMA presents the award to a member company or companies that demonstrate the value of distribution by developing creative, results-oriented programs and processes in areas ranging from technology and operations to trade and promotional planning that benefit the healthcare supply chain, customers and consumers, and engage in successful trading partner relationships.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Ponsegromab Significantly Improves Body Weight in Patients with Cancer Cachexia
September 17th 2024Results of a Phase II study of ponsegromab showed significant improvements in body weight, muscle function, and overall symptoms for patients with cancer cachexia, offering hope for a new targeted treatment.
Imfinzi Plus Imjudo Shows Significant Five-Year Survival Improvement in Unresectable Liver Cancer
September 16th 2024Data from the Phase III HIMALAYA trial found the combination of Imfinzi plus Imjudo reduced the risk of death by 24% compared to sorafenib in patients with unresectable hepatocellular carcinoma.